| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.39B | 40.09B | 30.50B | 27.32B | 25.79B | 23.35B |
| Gross Profit | 4.72B | 6.35B | 4.26B | 4.47B | 5.06B | 4.88B |
| EBITDA | 1.84B | 3.05B | 1.50B | 2.08B | 2.69B | 2.55B |
| Net Income | 1.09B | 1.83B | 880.15M | 1.26B | 1.74B | 1.62B |
Balance Sheet | ||||||
| Total Assets | 34.83B | 38.10B | 31.29B | 26.85B | 27.43B | 24.44B |
| Cash, Cash Equivalents and Short-Term Investments | 6.30B | 7.89B | 7.25B | 6.87B | 4.79B | 5.49B |
| Total Debt | 22.03B | 23.03B | 18.67B | 14.63B | 15.64B | 13.40B |
| Total Liabilities | 23.37B | 25.30B | 19.79B | 15.77B | 17.12B | 15.21B |
| Stockholders Equity | 11.46B | 12.79B | 11.49B | 11.08B | 10.30B | 9.23B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.17B | -3.11B | 3.57B | -2.34B | -1.56B |
| Operating Cash Flow | 0.00 | -3.16B | -1.60B | 4.55B | -706.53M | -1.28B |
| Investing Cash Flow | 0.00 | -41.87M | -1.62B | -1.25B | -1.55B | -434.60M |
| Financing Cash Flow | 0.00 | 3.83B | 3.54B | -1.50B | 1.58B | 1.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥11.66B | 13.54 | ― | 4.98% | 6.29% | 6.28% | |
76 Outperform | ¥21.90B | 11.93 | ― | 4.36% | -0.08% | -1.83% | |
67 Neutral | ¥30.69B | 16.05 | ― | 4.56% | 31.44% | 107.91% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥23.39B | 36.89 | ― | ― | -2.59% | 61.28% | |
59 Neutral | ¥14.11B | 6.08 | ― | 1.47% | 15.19% | -6.43% | |
52 Neutral | ¥15.26B | 16.24 | ― | 5.27% | -1.81% | 87.08% |